HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junichi Sakamoto Selected Research

hange-shashinto

1/2018The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).
7/2015Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
5/2014Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junichi Sakamoto Research Topics

Disease

84Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2002
61Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 09/2003
49Neoplasms (Cancer)
06/2022 - 09/2003
17Colonic Neoplasms (Colon Cancer)
10/2022 - 10/2004
17BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2020 - 12/2012
13Neoplasm Metastasis (Metastasis)
02/2021 - 08/2006
12Diarrhea
05/2018 - 01/2004
11Neutropenia
12/2020 - 01/2004
11Breast Neoplasms (Breast Cancer)
09/2014 - 02/2004
10Carcinoma (Carcinomatosis)
02/2022 - 05/2003
10Ascites
01/2020 - 05/2003
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021 - 05/2001
6Disease Progression
01/2018 - 07/2007
5Body Weight (Weight, Body)
10/2018 - 11/2004
5Adenocarcinoma
01/2018 - 07/2007
5Fatigue
01/2018 - 01/2004
5Stomatitis
01/2018 - 01/2004
4Lymphatic Metastasis
10/2020 - 07/2009
4Anemia
01/2018 - 11/2008
4Hypersensitivity (Allergy)
09/2016 - 03/2013
4Leukopenia
08/2012 - 01/2004
3Rectal Neoplasms (Rectal Cancer)
01/2022 - 01/2018
3Pain (Aches)
10/2021 - 06/2009
3Lung Neoplasms (Lung Cancer)
05/2021 - 04/2017
3Wilms Tumor (Wilm's Tumor)
02/2019 - 05/2008
3Anorexia
01/2018 - 01/2004
3Obesity
01/2017 - 06/2014
3Glioblastoma (Glioblastoma Multiforme)
09/2016 - 05/2008
3Thrombocytopenia (Thrombopenia)
01/2014 - 02/2006
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 11/2004
2Ileus
01/2020 - 08/2015
2Multiple Myeloma
10/2019 - 12/2007
2Infections
04/2018 - 08/2010
2Esophageal Neoplasms (Esophageal Cancer)
01/2017 - 01/2004
2Sarcoma (Soft Tissue Sarcoma)
12/2016 - 10/2014
2Peripheral Nervous System Diseases (PNS Diseases)
12/2016 - 10/2013
2Proteinuria
12/2016 - 12/2003
2Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
05/2016 - 04/2013
2Hypertension (High Blood Pressure)
10/2015 - 01/2010

Drug/Important Bio-Agent (IBA)

36Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 05/2003
26Capecitabine (Xeloda)FDA Link
10/2022 - 02/2004
25Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 11/2003
21Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2004
20Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022 - 12/2011
19Irinotecan (Camptosar)FDA LinkGeneric
11/2021 - 06/2004
15Dasatinib (BMS 354825)FDA Link
03/2020 - 01/2014
14Cetuximab (Erbitux)FDA Link
06/2022 - 04/2014
13Bevacizumab (Avastin)FDA Link
11/2021 - 01/2011
12Leucovorin (Folinic Acid)FDA Link
10/2022 - 12/2011
11Peptides (Polypeptides)IBA
02/2019 - 06/2007
8TegafurIBA
02/2022 - 04/2010
8Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2003
8XELOXIBA
01/2017 - 01/2011
7UracilIBA
02/2022 - 07/2014
6Pharmaceutical PreparationsIBA
01/2021 - 02/2006
6Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 10/2010
5Panitumumab (Vectibix)FDA Link
12/2022 - 01/2017
5pyrimidineIBA
01/2022 - 09/2003
5Tyrosine Kinase InhibitorsIBA
03/2020 - 10/2017
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2019 - 02/2004
5Protein Subunit VaccinesIBA
01/2018 - 04/2006
4VaccinesIBA
02/2019 - 05/2008
4S-1 plus cisplatinIBA
01/2018 - 04/2010
4PicibanilIBA
04/2016 - 05/2001
3Indicators and Reagents (Reagents)IBA
01/2022 - 10/2004
3Carcinoembryonic AntigenIBA
01/2022 - 01/2003
3gosha-jinki-ganIBA
10/2021 - 12/2009
3Messenger RNA (mRNA)IBA
07/2020 - 06/2007
3ErbB Receptors (EGF Receptor)IBA
11/2019 - 09/2011
3Carboplatin (JM8)FDA LinkGeneric
11/2019 - 04/2017
3HLA-A*24:02 antigenIBA
02/2019 - 02/2014
3hange-shashintoIBA
01/2018 - 05/2014
3polysaccharide-KIBA
01/2018 - 04/2006
3Trastuzumab (Herceptin)FDA Link
01/2017 - 09/2011
3Epidermal Growth Factor (EGF)IBA
01/2017 - 07/2014
3Monoclonal AntibodiesIBA
01/2017 - 11/2006
3Alanine Transaminase (SGPT)IBA
12/2016 - 11/2008
3AntigensIBA
11/2006 - 01/2003
2CytokinesIBA
01/2020 - 08/2010
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2019 - 12/2015
2Drinking WaterIBA
05/2018 - 06/2010
2CreatinineIBA
01/2018 - 12/2003
2Phosphotransferases (Kinase)IBA
10/2017 - 01/2014
2taxaneIBA
01/2017 - 04/2013
2Immunoglobulin G (IgG)IBA
09/2016 - 08/2010
2thiamine triphosphorate (TTP)IBA
07/2016 - 08/2006
2LentinanIBA
01/2016 - 07/2009

Therapy/Procedure

60Drug Therapy (Chemotherapy)
06/2022 - 01/2002
59Therapeutics
10/2022 - 09/2003
38Adjuvant Chemotherapy
09/2022 - 01/2004
14Gastrectomy
02/2021 - 01/2004
12Neoadjuvant Therapy
07/2020 - 01/2003
7Lymph Node Excision (Lymph Node Dissection)
11/2021 - 01/2004
6Combination Drug Therapy (Combination Chemotherapy)
08/2012 - 11/2003
5Immunotherapy
01/2018 - 12/2007
4Drug Tapering
12/2020 - 02/2006
4TP protocol
01/2014 - 04/2007
3Oral Administration
05/2021 - 01/2015
3Pancreaticoduodenectomy
01/2020 - 04/2013
3Kampo Medicine (Kampo)
07/2015 - 04/2013